Medicare Enrolled
Dr. Lucas Margolies, M.D.
Neurology · Wynnewood, PA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Margolies from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Margolies?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Margolies
Dr. Lucas Margolies is a neurology specialist in Wynnewood, PA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Margolies performed 1,092 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Margolies received a total of $9,677 from 72 pharmaceutical and/or device companies across 521 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Margolies is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 11% volume in PA
$9,677 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗1,092
Medicare services
Top 11% in PA for neurology
Not available
Unique patients (not deduplicated)
$101
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
251 | $96 | $235 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
220 | $125 | $366 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
188 | $66 | $155 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
173 | $75 | $267 |
| Nerve conduction studies, 5-6 tests A series of 5 to 6 tests that measure how well nerves send electrical signals. The procedure evaluates nerve function and helps identify damage or dysfunction. |
74 | $91 | $418 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
62 | $135 | $326 |
| New patient office visit, complex (60-74 min) | 60 | $176 | $480 |
| Nerve conduction studies, 7-8 tests A series of 7 to 8 nerve conduction tests to evaluate how well nerves are sending signals to muscles. |
31 | $132 | $560 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
19 | $83 | $264 |
| Nerve conduction study, 9-10 studies A diagnostic test that measures how well nerves send electrical signals. It involves performing 9 to 10 separate nerve conduction studies to evaluate nerve function. |
14 | $174 | $600 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$9,677
Total received (2018-2024)
Avg $1,382/year across 7 years
Top 21% in PA for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
72
Companies
521
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,521
2023
$1,303
2022
$1,441
2021
$534
2020
$962
2019
$2,110
2018
$1,806
Payments by company (2024)
ABBVIE INC.
$273
ARGENX US, INC.
$222
Genentech USA, Inc.
$102
Celgene Corporation
$87
Amneal Pharmaceuticals LLC
$87
CSL Behring
$85
PFIZER INC.
$77
ACADIA Pharmaceuticals Inc
$66
Alnylam Pharmaceuticals Inc.
$63
Alexion Pharmaceuticals, Inc.
$61
Takeda Pharmaceuticals U.S.A., Inc.
$59
Medtronic, Inc.
$59
Biogen, Inc.
$51
UCB, Inc.
$42
MDD US Operations, LLC
$40
Eisai Inc.
$33
Grifols USA, LLC
$29
Kyowa Kirin, Inc.
$20
Acorda Therapeutics, Inc
$18
Teva Pharmaceuticals USA, Inc.
$17
Lundbeck LLC
$16
GE HEALTHCARE
$13
Top 3 companies account for 39.3% of 2024 payments
All-time payments by company (2018-2024) ›
ABBVIE INC.
$1,016
Biogen, Inc.
$810
Sunovion Pharmaceuticals Inc.
$566
Novartis Pharmaceuticals Corporation
$445
Teva Pharmaceuticals USA, Inc.
$415
UCB, Inc.
$408
ARGENX US, INC.
$397
ACADIA Pharmaceuticals Inc
$376
Genentech USA, Inc.
$356
Alexion Pharmaceuticals, Inc.
$286
Acorda Therapeutics, Inc
$275
PFIZER INC.
$234
Adamas Pharmaceuticals, Inc.
$224
AbbVie Inc.
$196
Alnylam Pharmaceuticals Inc.
$192
Amneal Pharmaceuticals LLC
$190
Avanir Pharmaceuticals, Inc.
$169
GENZYME CORPORATION
$160
CSL Behring
$159
Celgene Corporation
$149
UPSHER-SMITH LABORATORIES LLC
$126
Merz North America, Inc.
$119
Lundbeck LLC
$118
EMD Serono, Inc.
$110
Lilly USA, LLC
$102
MDD US Operations, LLC
$99
Upsher-Smith Laboratories LLC
$97
Allergan Inc.
$94
Abbott Laboratories
$93
Nevro Corp.
$92
Promius Pharma LLC
$88
Allergan, Inc.
$87
Eisai Inc.
$86
Takeda Pharmaceuticals U.S.A., Inc.
$73
MERZ NORTH AMERICA, INC.
$67
Amgen Inc.
$65
E.R. Squibb & Sons, L.L.C.
$64
Medtronic, Inc.
$59
Avion Pharmaceuticals
$55
SANOFI-AVENTIS U.S. LLC
$50
Vertical Pharmaceuticals, LLC
$49
Banner Life Sciences, LLC
$49
EISAI INC.
$48
US WorldMeds, LLC
$48
Sumitomo Pharma America, Inc.
$48
Mitsubishi Tanabe Pharma America, Inc.
$46
Medtronic Vascular, Inc.
$46
Akcea Therapeutics, Inc.
$46
Biohaven Pharmaceutical Holding Company Ltd.
$40
Kyowa Kirin, Inc.
$37
ARBOR PHARMACEUTICALS, INC.
$36
W. L. Gore & Associates, Inc.
$35
Grifols USA, LLC
$29
DePuy Synthes Sales Inc.
$26
Mylan Pharmaceuticals Inc.
$24
Averitas Pharma Inc.
$24
GRT US Holding, Inc.
$24
Boston Scientific Corporation
$23
PORTOLA PHARMACEUTICALS, INC.
$22
Neurocrine Biosciences, Inc.
$21
Ipsen Biopharmaceuticals, Inc
$20
Assertio Therapeutics, Inc.
$18
BOSTON SCIENTIFIC CORPORATION
$18
IMPEL PHARMACEUTICALS INC.
$16
JAZZ PHARMACEUTICALS INC.
$16
Egalet US Inc
$15
SK Life Science, Inc.
$15
Janssen Pharmaceuticals, Inc
$15
Merz Pharmaceuticals, LLC
$14
GE HealthCare
$14
GE HEALTHCARE
$13
Bayer HealthCare Pharmaceuticals Inc.
$13
Top 3 companies account for 24.7% of all-time payments
Associated products mentioned in payments ›
AIMOVIG · AJOVY · AMPYRA · AMVUTTRA · ANDEXXA · APOKYN · APTIOM · AUBAGIO · AUSTEDO · Aimovig · Austedo XR · BAFIERTAM · BOTOX · BOTOX COSMETIC · BOTOX THERAPEUTIC · Betaseron · Briviact · COMIRNATY · COPAXONE · Cambia · DUOPA · Dhivy · Dysport · EMGALITY · EPIDIOLEX · Fycompa · GAMMAGARD · GILENYA · GOCOVRI · GORE CARDIOFORM Septal Occluder · Gamunex-C · Glatiramer Acetate · Gocovri · HYQVIA · Hizentra · Horizant · INBRIJA · INFINITY · Infinity DBS Pulse Generators · KESIMPTA · KYNMOBI · LEMTRADA · LEQEMBI · Leqembi · MATRIXNEURO · MAVENCLAD · MAYZENT · MYOBLOC · NAMZARIC · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Neupro · Nourianz · Nuedexta · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONFI · ONGENTYS · ONGENTYS 50MG CAPSULES 30 · ONPATTRO · OSMOLEX ER · Ocrevus · Ongentys · PANZYGA · PAXLOVID · PERCEPT PC BRAINSENSE · Ponvory · QALSODY · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · QUTENZA · Quattrode Leads SCS Leads · Qutenza · RADICAVA · RELEXXII · RYTARY · Radicava · Rebif · Reveal LINQ · Rystiggo · SOLIRIS · SPRIX · Senza Spinal Cord Stimulation System · Soliris · TECFIDERA · TEGSEDI · THROMBIN-JMI · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TYSABRI · Trudhesa · UBRELVY · ULTOMIRIS · VUMERITY · VYALEV · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · WATCHMAN · XEOMIN · Xadago · Xeomin · ZEMBRACE SYMTOUCH · ZEPOSIA · Zembrace · Zembrace SymTouch Sumatriptan Injection · Zilbrysq
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Neurologists in nearby ZIP areas
509
County median income
$111,521
Nearest hospital to ZIP centroid (approximate)
MAIN LINE HOSPITAL LANKENAU
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Margolies is a clinical cardiology specialist, with above-average Medicare volume (top 11% in PA), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Margolies experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Margolies performed 251 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Margolies receive payments from pharmaceutical companies?
Yes. Dr. Margolies received a total of $9,677 from 72 companies across 521 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Margolies's costs compare to other neurologists in Wynnewood?
Dr. Margolies's average Medicare payment per service is $101. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Margolies) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Wynnewood
Browse neurologists in Wynnewood ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in PA
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in PA
Which PA neurologists receive the most from drug and device companies.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
Biogen, Inc. Payments to Doctors
See all physicians who received payments from Biogen, Inc.
By company
Sunovion Pharmaceuticals Inc. Payments to Doctors
See all physicians who received payments from Sunovion Pharmaceuticals Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology